Human Factor XIIIa, Thrombin activated

Human Factor XIIIa, Thrombin activated

Catalog Number:
E001055234ZED
Mfr. No.:
T070
Price:
$907
Size:
200 µg
Quantity:
Add to Cart:
    • Overview
      • Recombinant human Factor XIII is a homodimer (a2) composed of two chains held together by non covalent bonds. After activation of the zymogen by Thrombin and Ca2+ to its active form (a*2, Factor XIIIa), Factor XIIIa catalyzes the formation of covalent bridges (ε-(γ-glutamyl) lysine bonds) between fibrin units to increase the elasticity of the clot network. The resulting cross-linked fibrin is insoluble and resistant to lysis.

        Please contact us at for specific academic pricing.

        More Details

    • Properties
      • Name
        Recombinant Fibrin stabilizing factor
        Source
        Insect cells
        Type
        Recombinant Proteins
        Purification
        > 95% [by SDS-PAGE]
        Formulation
        The recombinant human Factor XIIIa is lyophilized from 50 mM Tris-HCl pH 7.4, 300 mM NaCl, 1 mM CHAPS, 3 mM Ca2+. Sample contains sucrose.
        Storage
        Storage for several months is possible at ≤ - 20°C. Delivery is possible at ambient temperature
        Note
        INTENDED FOR RESEARCH USE ONLY, NOT FOR USE IN HUMAN, THERAPEUTIC OR DIAGNOSTIC APPLICATIONS.
        Molecular Weight
        78 kDa
        Class
        Human Factor XIII-A2
        Reconstitution
        Add the volume of water specified in the certificate of analysis under aliquotation to the vial of lyophilized powder. Rotate vial gently until solid dissolves. After reconstitution the solution should be stored frozen in working aliquots. For short term storage keep cooled on ice.
    • Applications
      • Application Description
        rhFXIIIa catalyzes acyl transfer reactions from glutamine residues in proteins or peptides to primary amines, e. g. the formation of ε-(γ-glutamyl) lysine bonds between proteins by transferring the acyl group of a peptide-bound glutamine residue to the primary amino group of a peptide-bound lysine residue.
    • Reference
      • Chrobok et al., PLoS One. 2018, 13:e0196433
        Akbar et al., J. Med. Chem. 2017, 60:7910-27
        de Jager, M. et al., Neuropathol. Appl. Neurobiol. 2016, 42, 255
        Hamedani et al., Chem. Commun. 2015, 51, 1135-39
        Böhm et al,. J. Med. Chem. 2014, 57:10355-65